Management of preterm giant sacrococcygeal teratoma (GSCT) with an excellent outcome

Infants born with a giant sacrococcygeal teratoma (GSCT; >10 cm) have high mortality. Risk factors for mortality include increased tumor vascularity, high cardiac output, rapid growth, diagnosis before 20-week gestation, delivery before 30-week gestation, hydrops, low birth weight, Apgar less tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Gangadharan, Meera, Panda, Sanjeet, Almond, P. Stephen, Agrawal, Vaidehi, Bhandari, Angelina, Koska, A. Jay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256527/
https://www.ncbi.nlm.nih.gov/pubmed/25480837
http://dx.doi.org/10.1093/jscr/rju132
Descripción
Sumario:Infants born with a giant sacrococcygeal teratoma (GSCT; >10 cm) have high mortality. Risk factors for mortality include increased tumor vascularity, high cardiac output, rapid growth, diagnosis before 20-week gestation, delivery before 30-week gestation, hydrops, low birth weight, Apgar less than 7 at 5 min and polyhydramnios. We present the case of a 28-week infant born with a GSCT (15 × 12 × 16 cm) and all of these risk factors.

Ejemplares similares